sodium acetate

Small moleculeapproved

Approved

Sep 24, 1971

Sodium acetate, CH3COONa, also abbreviated NaOAc, is the sodium salt of acetic acid. This salt is colorless, deliquescent, and hygroscopic. — Wikipedia

Clinical trial activity

32 trials · 40 clinical orgs · 13 marketing orgs

Phase 1
3
Phase 2
12
Phase 3
6
Phase 4
9

Earliest trial started Jan 1, 2008 (NCT00801359)

Timeline

1970s

  1. Sep 24, 1971

    B. Braun — Earliest FDA Approval

  2. Sep 24, 1971

    Evidence of US Marketing

  3. Sep 24, 1971

    B. Braun — Marketing Organization

  4. Sep 24, 1971

    B. Braun — NDA Secondary Org

  5. Sep 24, 1971

    B. Braun — NDA Organization

  6. Aug 13, 1975

    ICU Medical Inc — Marketing Organization

  7. Aug 13, 1975

    ICU Medical Inc — NDA Secondary Org

  8. Mar 24, 1976

    Baxalta — Marketing Organization

  9. Mar 24, 1976

    Baxter — NDA Secondary Org

  10. Jan 3, 1978

    Hospira — Marketing Organization

1980s

  1. May 4, 1983

    Hospira — NDA Secondary Org

1990s

  1. Dec 10, 1997

    Alcon — Marketing Organization

  2. Dec 10, 1997

    Nestle — NDA Secondary Org

2000s

  1. Sep 27, 2006

    Akorn, Inc. — Marketing Organization

  2. Sep 27, 2006

    Epic Pharma Llc — Marketing Organization

  3. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

  2. Aug 25, 2014

    Fresenius — Marketing Organization

  3. Aug 25, 2014

    Fresenius — NDA Secondary Org

2020s

  1. May 4, 2021

    Milla Pharms — Marketing Organization

  2. Jan 1, 2022

    Earliest Phase 3 Sponsor(trial)

  3. Mar 15, 2024

    Hikma — Marketing Organization

Indications

Mechanism of action

Combination products

Approval history

  • approvedPriority reviewSep 24, 1971
  • approvedPriority reviewSep 24, 1971

Chemistry & pharmacology

Loading structure…

SMILES

[Na+].CC([O-])=O
Mol. weight
82.0338 g/mol
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Prescription Only

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • 13c-sodium acetate
  • acetic acid, sodium salt
  • acetic acid, sodium salt
  • acetic acid, sodium salt
  • acetic acid, sodium salt (1:1)
  • acetic acid, sodium salt (1:1)
  • anhydrous sodium acetate
  • anhydrous sodium acetate
  • anhydrous sodium acetate
  • e262
  • e262
  • natriumazetat
  • natriumazetat
  • short chain fatty acids
  • short chain fatty acids
  • sodium acetate
  • sodium acetate
  • sodium acetate
  • sodium acetate
  • sodium acetate
  • sodium acetate
  • sodium acetate
  • sodium acetate
  • sodium acetate anhydrous
  • sodium acetate anhydrous
  • sodium acetate anhydrous
  • sodium acetate anhydrous
  • sodium acetate,anhydrous
  • sodium acetate,anhydrous
  • sodium acetate, anhydrous
  • sodium acetate, anhydrous
  • sodium acetate, anhydrous

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06663254Phase 4Nov 30, 2024Central South University
NCT06545565Phase 3Jul 10, 2024Aga Khan University
NCT06354088Phase 1Apr 24, 2024Columbia University, University of California, Berkeley
NCT05345171Phase 3Dec 31, 2022Ultragenyx Inc.
NCT05253209Phase 3Jun 29, 2022Asklepion, Indiana University
NCT03338218Phase 4May 1, 2018B. Braun, European Society of Anaesthesiology, Fresenius, Maastricht University
NCT03278548Phase 4Sep 28, 2017B. Braun, European Society of Anaesthesiology, Fresenius, Maastricht University
NCT03204955Phase 1Jun 28, 2017Emory University
NCT02826395N/AJul 5, 2016University of California, Los Angeles
NCT02805257Phase 2Jun 1, 2016Asociación para Evitar la Ceguera en México, Bascom Palmer Eye Institute, Sun Yat-Sen University, University of California, San Francisco, University of Colorado, Denver, University of Maryland, University of North Carolina at Chapel Hill
NCT02715466Phase 4Apr 1, 2016B. Braun
NCT02707549Phase 2Aug 1, 2015University of Sao Paulo
NCT02435862Phase 2Apr 1, 2015Allegro Ophthalmics, LLC, Duke University, Trial Runners, LLC
NCT02623777N/AMar 1, 2015Katholieke Universiteit Leuven
NCT02563847N/AMay 1, 2014University of Bern
NCT01961934Phase 2/Phase 3 (Phase 3)May 1, 2014Phoenix Molecular Imaging
NCT02051946Phase 1/Phase 2 (Phase 2)May 1, 2014Duke University
NCT02153476Phase 2Feb 1, 2014Allegro Ophthalmics, LLC
NCT03001466Phase 2Jan 1, 2014Assiut University
NCT01851616N/AJan 1, 2013University of Basel, University of Bern
Showing 20 of 32 trials
Page 1 / 2

Organizations

Research & Development (40)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
B. BraunFor profit4412010
AlconFor profit3222008
FreseniusFor profit3012011
Allegro Ophthalmics, LLCFor profit2212014
Duke UniversityAcademic/Hospital2112014
European Society of AnaesthesiologyAcademic/Hospital2012017
Maastricht UniversityAcademic/Hospital2012017
Phoenix Molecular ImagingAcademic/Hospital2222011
Thomas Jefferson UniversityAcademic/Hospital2212009
University of BernAcademic/Hospital2212013
University of Sao PauloAcademic/Hospital2212008
Aga Khan UniversityAcademic/Hospital1112024
AsklepionFor profit1112022
Asociación para Evitar la Ceguera en MéxicoAcademic/Hospital1012016
Assiut UniversityAcademic/Hospital1112014
Bascom Palmer Eye InstituteAcademic/Hospital1012016
BayerFor profit1012011
Central South UniversityAcademic/Hospital1112024
CLIHONAcademic/Hospital1012010
Columbia UniversityAcademic/Hospital1112024
40 organizations
Page 1 / 2

Marketing (18)

OrganizationOrg typeRelationshipDate
AbbottFor profitNDA2
Akorn, Inc.For profitMKTGSep 27, 2006
AlconFor profitMKTGDec 10, 1997
B. BraunFor profitMKTGSep 24, 1971
B. BraunFor profitNDA2Sep 24, 1971
B. BraunFor profitNDASep 24, 1971
BaxaltaFor profitMKTGMar 24, 1976
BaxterFor profitNDA2Mar 24, 1976
Epic Pharma LlcFor profitMKTGSep 27, 2006
FreseniusFor profitMKTGAug 25, 2014
FreseniusFor profitNDA2Aug 25, 2014
HikmaFor profitMKTGMar 15, 2024
HospiraFor profitNDA2May 4, 1983
HospiraFor profitMKTGJan 3, 1978
ICU Medical IncFor profitMKTGAug 13, 1975
ICU Medical IncFor profitNDA2Aug 13, 1975
Milla PharmsFor profitMKTGMay 4, 2021
NestleFor profitNDA2Dec 10, 1997